Ceres loses $6.8M in Q1
Energy crop company Ceres lost $6.8 million in the first quarter, it said in its first earnings report after going public in a $65.3 million IPO in late February. The Thousand Oaks-based firm’s loss widened from $5.4 million a year earlier as revenue dropped from $1.6 million to $1.3 million. Despite a $100,000 increase in Read More →
Founders earnings jump in Q1
San Luis Obispo-based Founders Community Bank earned $189,000 in the first quarter, up 220 percent from the $86,000 it earned in the first quarter a year earlier. The bank also announced plans to open a new Morro Bay branch. Loans and deposits were up during the quarter, with noninterest-bearing deposits climbing by $7 billion, CEO Read More →
Umpqua to buy American Perspective Bank for $44.7M
San Luis Obispo-based American Perspective Bank is being purchased by Portland-based Umpqua Holdings Corp. for $44.7 million. Under the deal, announced April 10, Umpqua will pay $10 per share in cash for American Perspective. The San Luis Obispo bank’s three Central Coast branches will be rebranded as Umpqua Bank. The acquisition has been approved by Read More →
Calavo to raise up to $200M
Avocado marketer Calavo Growers said April 6 that it plans to raise up to $200 million in fresh capital by offering a mix of common stock and warrants for sale. The Santa Paula-based company said in regulatory filings that it would offer a combination of shares of common stock and warrants to raise the funds. Read More →
Teledyne increases stake in Optech
Military-industrial conglomerate Teledyne Technologies said April 3 that its Dalsa subsidiary has increased its ownership stake in the parent company of Optech from 19 percent to 51 percent. Terms of the deal were not disclosed. Optech is a Canadian maker of laser-based survey and digital imaging equipment. Thousand Oaks-based Teledyne has been moving away from Read More →
Amgen, AstraZeneca strike drug development deal
Amgen has entered a development deal with London-based AstraZeneca to jointly commercialize five anti-inflammation drugs. Under the terms of the agreement announced April 2, AstraZeneca will pay a one-time $50 million payment to Amgen and will be responsible for helping the Thousand Oaks-based biotech giant commercialize its inflammation drug pipeline. The firms said in a Read More →
